Comparison of Short Interval and Low Dose (SILD) with High Dose of Cyclophosphamide in the Susceptibility to Infection in SLE: a Multicentrereal-World Study
Miao Shao,Miao,Xia Zhang,Xiaoying Zhang,Yuan An,Huifang Guo,Lingyan Lei,Qing Zhao,Yanjie Ding,Jin Lin,Rui Wu,Feng Yu,Yucui Li,Huali Miao,Liyun Zhang,Yan Du,Ruiying Jiao,Lixia Pang,Li Long,Xueming Yao,Xiaofei Shi,Fei Wang,Luping Cui,Lei Zhang,Shengyun Liu,Fuai Lu,Kangkai Luo,Simeng Zhao,Yongfu Wang,Xiao Wu,Qingwen Wang,Hongjiang Liu,Shulin Song,Xiaoyuan Zhou,Xiaoping Zhang,Shumei Shi,Hong Zhu,Yao Chen,Honglian Yu,Jie Wu,Ruiyun Yu,Wenqiang Fan,Shuang Liu,Jian Xu,Zhibin Chen,Lianjie Shi,Jing He,Xuewu Zhang,Zhanguo Li,Ru Li
DOI: https://doi.org/10.1136/lupus-2022-000779
IF: 4.687
2022-01-01
Lupus Science & Medicine
Abstract:ObjectiveInfection is a major cause of death in patients with SLE. This study aimed to explore the infection rate in patients with SLE receiving a low dose of intravenous cyclophosphamide (IV-CYC).MethodsClinical parameters of 1022 patients with SLE from 24 hospitals in China were collected. Patients were divided into the short-interval and lower-dose (SILD, 400 mg every 2 weeks) IV-CYC group and the high-dose (HD, 500 mg/m(2) of body surface area every month) IV-CYC group. The clinical data and infection rate between the two groups were compared.ResultsCompared with HD IV-CYC, the infection rate of the SILD IV-CYC group was significantly lower (13.04% vs 22.27%, p=0.001). Respiratory tract infection (10.28% vs 15.23%, p=0.046) and skin/soft tissue infection (1.78% vs 4.3%, p=0.040) were significantly decreased in the SILD IV-CYC group. Moreover, infections occurred most likely in patients with SLE with leucopenia (OR 2.266, 95% CI 1.322 to 3.887, p=0.003), pulmonary arterial hypertension (OR 2.756, 95% CI 1.249 to 6.080, p=0.012) and >15 mg/day of glucocorticoid (OR 2.220, 95% CI 1.097 to 4.489, p=0.027).ConclusionsSILD IV-CYC showed a lower frequency of infection events than high-dose IV-CYC in patients with SLE.